Literature DB >> 8995647

Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain.

J Arroyo1, E Winchester, B S McLellan, B T Huber.   

Abstract

Superantigens have the ability to stimulate subsets of T lymphocytes bearing particular T-cell receptor Vbeta chains. The best-known viral superantigen is Mls, a product of the murine mammary tumor virus (MMTV) sag gene. The MMTV superantigen is not displayed by the virus itself; however, after infection of B lymphocytes, the superantigen is expressed. The resulting immune stimulation is essential for viral transmission. We have analyzed the transcriptional elements which control Mls-1 expression. Here we present evidence that a region at the 3' end of Mtv-7 env, Penv2, controls B-cell-specific expression of sag. Penv2 has elements homologous with promoters of immunoglobulin H chain, the invariant chain, and major histocompatibility complex class II, suggesting a coordinate regulation of expression of these various B-cell-specific genes and indicating a possible eukaryotic origin of MMTV sag. We have determined that both an IgH heptamer element and a Y box are essential for Penv2 promoter activity and that tandem octamer motifs in the U3 region of the 3' MMTV long terminal repeat function as enhancers. We propose that Penv2 controls constitutive Mls expression in B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995647      PMCID: PMC191178     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  The helix-loop-helix containing transcription factor USF activates the promoter of the CD2 gene.

Authors:  S V Outram; M J Owen
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

Review 2.  Assembly, transport, and function of MHC class II molecules.

Authors:  P Cresswell
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  Cloning in a plasmid of an MMTV from a wild Chinese mouse: sequencing of the viral LTR.

Authors:  L Xu; S Haga; S Imai; N H Sarkar
Journal:  Virus Res       Date:  1994-08       Impact factor: 3.303

4.  Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.

Authors:  C Morishima; C Norby-Slycord; K R McConnell; R J Finch; A J Nelson; A G Farr; A M Pullen
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

5.  Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: normal- and tumor-tissue-specific expression of int-3 transcripts.

Authors:  N H Sarkar; S Haga; A F Lehner; W Zhao; S Imai; K Moriwaki
Journal:  Virology       Date:  1994-08-15       Impact factor: 3.616

Review 6.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

7.  Two independent pathways for transcription from the MMTV promoter.

Authors:  C C Möws; T Preiss; E P Slater; X Cao; C P Verrijzer; P C van Der Vliet; M Beato
Journal:  J Steroid Biochem Mol Biol       Date:  1994-10       Impact factor: 4.292

8.  Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.

Authors:  T V Golovkina; A Chervonsky; J P Dudley; S R Ross
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

9.  The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription.

Authors:  M Tanaka; W M Clouston; W Herr
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.

Authors:  C K Rudy; E Kraus; E Palmer; B T Huber
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  8 in total

1.  Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.

Authors:  K Aurrekoetxea-Hernández; E Buetti
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.

Authors:  A Barnett; F Mustafa; T J Wrona; M Lozano; J P Dudley
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene.

Authors:  F Mustafa; M Lozano; J P Dudley
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway.

Authors:  M E Grigg; C W McMahon; S Morkowski; A Y Rudensky; A M Pullen
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 6.  Mouse mammary tumor virus molecular biology and oncogenesis.

Authors:  Susan R Ross
Journal:  Viruses       Date:  2010-09-23       Impact factor: 5.818

7.  Cross-packaging of genetically distinct mouse and primate retroviral RNAs.

Authors:  Noura Salem Al Dhaheri; Pretty Susan Phillip; Akela Ghazawi; Jahabar Ali; Elizabeth Beebi; Soumeya Ali Jaballah; Tahir A Rizvi
Journal:  Retrovirology       Date:  2009-07-14       Impact factor: 4.602

8.  Convergent capture of retroviral superantigens by mammalian herpesviruses.

Authors:  Amr Aswad; Aris Katzourakis
Journal:  Nat Commun       Date:  2015-09-24       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.